Week of June 6, 2023 | Vol. 12, Issue 22

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Indegene expands partnership with ConTIPI Medical Ltd to manage pelvic organ prolapse in women worldwide

Bourne Partners - May 24, 2023

ConTIPI Medical Ltd Raises $40MM of Structured Capital from Capital IP Investment Partners and Ghost Tree Partners

Bourne Partners - June 6, 2023

FAR Biotech and Aragen Life Sciences Enter into a Collaboration to Advance Preclinical Program in Neurodegeneration

PR Newswire - May 30, 2023

InSilicoTrials, IBSA Group partner to expand AI use in drug development

Fierce Biotech - May 31, 2023

Triton Starts Sale of $1.5 Billion Specialty Pharma Firm Pharmanovia

Bloomberg - May 31, 2023

JSR Life Sciences Announces Operational Consolidation of KBI Biopharma, Inc. and Selexis SA to Operate as one Organization, Providing Seamless Experience for Partners

Business Wire - May 31, 2023

Alcanza, Climb ink partnership to streamline digital clinical trials for participants

Fierce Biotech - May 31, 2023

Roche To Divest Legacy Genentech Facility in Vacaville, California, as Part of Long-term Strategy to Evolve Manufacturing Capabilities

Roche - May 31, 2023

Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSourceSM Laboratory

Business Wire - May 31, 2023

Rentschler Biopharma, Ikarovec Partner on Gene Therapies for Ophthalmic Disease

Contract Pharma - June 1, 2023

Lonza Acquires Synaffix for €100M

Contract Pharma - June 1, 2023

TANNER NEWS

Epimune & Tanner Pharma Ensure Patients in LATAM have Access to Advanced Diagnostics

Tanner recently traveled to Peru to conduct a comprehensive training session on Epimune’s groundbreaking i.Mune TBNK® test kit. The training aimed to prepare the local team for the official launch of this innovative test kit, which will soon be available in Peru. This IVD product quantifies CD3+, CD4+, CD8+ T-, B-, and NK lymphocytes in fresh blood or a dried blood spot (DBS). Read more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.